Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vagus Nerve Stimulation For Heart Failure Fails To Impress, But BioControl Not Bothered

This article was originally published in The Gray Sheet

Executive Summary

Boston Scientific and Cyberonics report disappointing data on vagus nerve stimulation to treat heart failure at the European Society of Cardiology conference in Barcelona. But another developer of a VNS system for heart failure, BioControl, says the results won’t affect its chances for approval.

Advertisement

Related Content

Cyberonics, Sorin Seek Critical Mass With Merger
People Briefs: Edwards Lifesciences, Cyberonics, Heartflow and Direct Flow
European Approval For BioControl Medical’s Nerve Stimulation System For Treatment-Resistant Depression
Emerging Peripheral Nerve Technologies Draw New Competitors To Neuromodulation Market

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT033292

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel